𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix®) with corresponding monovalent vaccines (Havrix® and Engerix-B®) in adults

✍ Scribed by Ronald W Joines; Mark Blatter; Betsy Abraham; Fang Xie; Norbert De Clercq; Yaela Baine; Keith S Reisinger; A Kuhnen; Dennis L Parenti

Book ID
117430533
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
138 KB
Volume
19
Category
Article
ISSN
0264-410X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Five-year follow-up of a prospective ran
Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: Immunogenicity and anamnestic responses
✍ Dr. Ching-Lung Lai; Benjamin Chun-Yu Wong; Eng-Kiong Yeoh; Wai-Ling Lim; Wai-Kwa 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 517 KB

In a prospective randomized trial, 318 children aged between 3 mo and 11 yr who were negative for all hepatitis B markers were randomized to receive two 5-pg doses of hepatitis B recombinant DNA yeast vaccine at 0 and 1 m o (group 11, three 5 -~g doses of hepatitis B recombinant DNA yeast vaccine at

Long-term persistence of antibodies indu
Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults
✍ P. Van Damme; G. Leroux-Roels; B. Law; F. Diaz-Mitoma; I. Desombere; F. Collard; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

## Abstract It is important to monitor the long‐term persistence of antibodies induced by vaccination. Four cohorts were followed for their long‐term immunity after vaccination with a combined hepatitis A and B vaccine (Twinrix; SmithKline Beecham Biologicals, Rixsenart, Belgium). Two cohorts of ad